{"id":"https://openalex.org/W1504184527","doi":null,"title":"Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.","display_name":"Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.","publication_year":2003,"publication_date":"2003-09-01","ids":{"openalex":"https://openalex.org/W1504184527","mag":"1504184527","pmid":"https://pubmed.ncbi.nlm.nih.gov/14506186"},"language":"en","primary_location":{"id":"pmid:14506186","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14506186","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017631627","display_name":"Frank G. van Schaijk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank G van Schaijk","raw_affiliation_strings":["University Medical Center Nijmegen, Nijmegen, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Medical Center Nijmegen, Nijmegen, the Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056620057","display_name":"Egbert Oosterwijk","orcid":"https://orcid.org/0000-0001-5049-0018","observed_orcids":["https://orcid.org/0000-0001-5049-0018"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Egbert Oosterwijk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052110459","display_name":"Annemiele C Soede","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annemiele C Soede","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000396669","display_name":"Wim J.G. Oyen","orcid":"https://orcid.org/0000-0001-8235-7078","observed_orcids":["https://orcid.org/0000-0001-8235-7078"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wim J G Oyen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"William J McBride","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William J McBride","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072370404","display_name":"Gary L. Griffiths","orcid":"https://orcid.org/0000-0002-6252-1309","observed_orcids":["https://orcid.org/0000-0002-6252-1309"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary L Griffiths","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003890903","display_name":"David M. Goldenberg","orcid":"https://orcid.org/0000-0001-5539-421X","observed_orcids":["https://orcid.org/0000-0001-5539-421X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David M Goldenberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111582633","display_name":"Frans H.M. Corstens","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frans H M Corstens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5012764804","display_name":"Otto C. Boerman","orcid":"https://orcid.org/0000-0001-6832-101X","observed_orcids":["https://orcid.org/0000-0001-6832-101X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Otto C Boerman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0707,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.76255135,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"9","issue":"10 Pt 2","first_page":"3880S","last_page":"5S"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pretargeting","display_name":"pretargeting","score":0.9259999990463257},{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.7450000047683716},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.9909999966621399},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.8759999871253967},{"id":"https://openalex.org/keywords/111in","display_name":"indium-111","score":0.781000018119812},{"id":"https://openalex.org/keywords/iodine-131","display_name":"iodine-131","score":1.0},{"id":"https://openalex.org/keywords/technetium-99m","display_name":"technetium-99m","score":0.9959999918937683},{"id":"https://openalex.org/keywords/rhenium-188","display_name":"rhenium-188","score":1.0},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.5979999899864197},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.9300000071525574},{"id":"https://openalex.org/keywords/tumor-to-blood-ratio","display_name":"tumor-to-blood ratio","score":0.621999979019165},{"id":"https://openalex.org/keywords/tumor-uptake","display_name":"tumor uptake","score":0.3529999852180481},{"id":"https://openalex.org/keywords/tumor-retention","display_name":"tumor retention","score":0.31299999356269836}],"concepts":[{"id":"https://openalex.org/C2777836882","wikidata":"https://www.wikidata.org/wiki/Q22907915","display_name":"Pretargeting","level":5,"score":0.9927686452865601},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.8263791799545288},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.7861491441726685},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6440565586090088},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6239977478981018},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.5619069933891296},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5344468951225281},{"id":"https://openalex.org/C2776620830","wikidata":"https://www.wikidata.org/wiki/Q4919211","display_name":"Bivalent (engine)","level":3,"score":0.47317197918891907},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3524000346660614},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35119765996932983},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24673891067504883},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20363545417785645},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20101341605186462},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13282257318496704},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.08688071370124817},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C544153396","wikidata":"https://www.wikidata.org/wiki/Q11426","display_name":"Metal","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004369","descriptor_name":"Pentetic Acid","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007205","descriptor_name":"Indium Radioisotopes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D007457","descriptor_name":"Iodine Radioisotopes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008239","descriptor_name":"Lysine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011868","descriptor_name":"Radioisotopes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D012211","descriptor_name":"Rhenium","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D013667","descriptor_name":"Technetium","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016499","descriptor_name":"Radioimmunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016719","descriptor_name":"Radioimmunodetection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"pmid:14506186","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14506186","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:repository.ubn.ru.nl:2066/142681","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2066/142681","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article / Letter to editor"},{"id":"pmh:ru:oai:repository.ubn.ru.nl:2066/142681","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2066/142681","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Cancer Research, 9, 3880S - 5S","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:1504184527","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14506186","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W139055546","https://openalex.org/W1543053385","https://openalex.org/W1545489655","https://openalex.org/W1608334591","https://openalex.org/W1848594274","https://openalex.org/W1945013834","https://openalex.org/W1973826816","https://openalex.org/W1996400431","https://openalex.org/W2026305248","https://openalex.org/W2058970445","https://openalex.org/W2088693735","https://openalex.org/W2107683656","https://openalex.org/W2108980544","https://openalex.org/W2134354949","https://openalex.org/W2150388160","https://openalex.org/W2183875932","https://openalex.org/W2184100701","https://openalex.org/W2317792746","https://openalex.org/W2345584500","https://openalex.org/W2615655254"],"related_works":["https://openalex.org/W1848594274","https://openalex.org/W1819330821","https://openalex.org/W1935729850","https://openalex.org/W2067044913","https://openalex.org/W2142704015","https://openalex.org/W2135136599","https://openalex.org/W2472614799","https://openalex.org/W3204120601","https://openalex.org/W2112893695","https://openalex.org/W2293039128"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,166,200],"therapeutic":[2],"effect":[3],"of":[4,20,75,109,122,160,204,225,236,242,262],"directly":[5],"labeled":[6,134,142],"antibodies":[7],"in":[8,24,96,222],"solid":[9],"tumors":[10,25],"is":[11],"limited,":[12],"mainly":[13],"due":[14],"to":[15],"the":[16,21,49,58,83,123,161,217,220,223,226,237,243,252,263,266,306],"relatively":[17],"low":[18],"uptake":[19,172,218,241],"radiolabeled":[22,124,255],"antibody":[23,91,112],"as":[26,249],"compared":[27,250],"with":[28,48,60,82,98,105,135,143,251,305],"their":[29],"blood":[30],"level.":[31],"In":[32,64],"previous":[33],"studies,":[34],"we":[35,67],"have":[36],"shown":[37],"that":[38],"renal":[39,76],"cell":[40,77],"carcinoma":[41],"(RCC)":[42],"can":[43,299],"be":[44,301],"targeted":[45],"very":[46],"effectively":[47],"(111)In-labeled":[50,167,238],"bivalent":[51,125,294],"peptide":[52,168,230,245],"di-diethylenetriamminepentaacetic":[53],"acid":[54],"diDTPA-FKYK,":[55],"after":[56],"pretargeting":[57,71,297],"tumor":[59,171,202,224,267],"a":[61,291],"bispecific":[62,89,110],"antibody.":[63],"this":[65,70,296],"study,":[66],"further":[68],"developed":[69,293],"approach":[72,298],"for":[73,303],"radioimmunotherapy":[74],"cancer.":[78],"EXPERIMENTAL":[79],"DESIGN:":[80],"Pretargeting":[81],"biologically":[84],"produced":[85],"anti-RCC":[86],"x":[87],"anti-DTPA":[88],"monoclonal":[90,111],"(bsMAb":[92],"G250xDTIn1)":[93],"was":[94,163,209,246,270],"tested":[95],"mice":[97,118],"SK-RC-52":[99],"RCC":[100],"tumors.":[101],"Tumors":[102],"were":[103,130,148,231],"pretargeted":[104],"15":[106],"micro":[107],"g":[108],"G250xDTIn1,":[113],"and":[114,139,153,158,183,192,206,219,228,280,310],"24":[115],"h":[116,155,181,190,198,214,278,287],"later,":[117],"received":[119],"6":[120,180,213,277],"ng":[121],"peptide.":[126,239],"Two":[127],"different":[128],"peptides":[129,208],"used:":[131],"(a)":[132],"diDTPA-FKYK":[133],"(111)In":[136],"or":[137,145],"(131)I;":[138],"(b)":[140],"thiosemicarbonylglyoxylcysteinyl-diDTPA(In)-KYKK":[141],"(99m)Tc":[144],"(188)Re.":[146],"Mice":[147],"killed":[149],"6,":[150],"24,":[151],"48,":[152],"72":[154,189,197,286],"postinjection":[156],"(p.i.),":[157],"biodistribution":[159],"radiolabel":[162,264],"determined.":[164],"RESULTS:":[165],"showed":[169],"excellent":[170],"[42.6":[173],"+/-":[174,185,273,282],"7.3%":[175],"injected":[176],"dose/gram":[177],"(ID/g)":[178],"at":[179,188,196,276,285],"p.i.":[182,279],"25.6":[184],"7.7%":[186],"ID/g":[187,275,284],"p.i.]":[191],"tumor:blood":[193],"ratios":[194],"(700":[195],"p.i.).":[199,215,288],"specific":[201],"targeting":[203,304],"(188)Re-":[205],"(99m)Tc-labeled":[207],"similar":[210],"(20-25%":[211],"ID/g,":[212],"However,":[216],"retention":[221],"(99m)Tc-":[227],"(188)Re-labeled":[229],"significantly":[232,247],"lower":[233,248],"than":[234],"those":[235],"Tumor":[240],"(131)I-labeled":[244],"other":[253],"three":[254],"peptides;":[256],"furthermore,":[257],"an":[258],"almost":[259],"complete":[260],"washout":[261],"from":[265],"over":[268],"time":[269],"observed":[271],"(14.5":[272],"4.9%":[274],"0.33":[281],"0.15%":[283],"CONCLUSIONS:":[289],"Using":[290],"newly":[292],"peptide,":[295],"now":[300],"used":[302],"matched":[307],"pair":[308],"(188)Re":[309],"(99m)Tc.":[311]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}